A Phase II Study of AT-101 to Overcome Bcl-2–Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 01, 2016
Source ID
10.1016/j.clgc.2015.09.010

Entities

People

  • Chandrika Jeyamohan
  • Glenn Liu
  • Howard L. Kaufman
  • Irina V. Tereshchenko
  • Janice Mehnert
  • Maha Hussain
  • Mark N. Stein
  • Robert S. Dipaola
  • Susan Goodin
  • Walter M. Stadler

Organizations

  • National Cancer Institute
  • National Institutes of Health
  • United States Department of Defense